Article: Ticagrelor: clinical development and future potential.
Reviews in cardiovascular medicine
2021 Volume 22, Issue 2, Page(s) 373–394
Abstract: Platelets participate centrally in atherothrombosis, resulting in vessel occlusion and ischaemia. Consequently, optimisation of antiplatelet regimens has the potential to further reduce the residual burden of morbidity and mortality associated with ... ...
Abstract | Platelets participate centrally in atherothrombosis, resulting in vessel occlusion and ischaemia. Consequently, optimisation of antiplatelet regimens has the potential to further reduce the residual burden of morbidity and mortality associated with atherosclerosis. Ticagrelor is a potent oral platelet P2Y |
---|---|
MeSH term(s) | Aspirin ; Brain Ischemia ; Humans ; Platelet Aggregation Inhibitors/adverse effects ; Stroke ; Ticagrelor/adverse effects |
Chemical Substances | Platelet Aggregation Inhibitors ; Ticagrelor (GLH0314RVC) ; Aspirin (R16CO5Y76E) |
Language | English |
Publishing date | 2021-07-14 |
Publishing country | Singapore |
Document type | Journal Article ; Review |
ZDB-ID | 2108910-3 |
ISSN | 1530-6550 |
ISSN | 1530-6550 |
DOI | 10.31083/j.rcm2202044 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6410: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.